Management of the asymptomatic carrier of the hepatitis-associated (Australia) antigen. Tentative considerations of the clinical and public-health aspects.
D001782:Blood Donors; D002353:Carrier State / Q000175:diagnosis* / Q000201:enzymology / Q000628:therapy*; D006281:Health Occupations; D006506:Hepatitis A / Q000209:etiology / Q000517:prevention & control*; D006511:Hepatitis B Antigens; D006515:Hepatitis B virus / Q000276:immunology*; D006801:Humans; D009784:Occupational Diseases / Q000517:prevention & control; D000637:Transaminases / Q000097:blood; D005719:gamma-Globulins / Q000627:therapeutic use
D006511:Hepatitis B Antigens; D005719:gamma-Globulins; D000637:Transaminases